Integration of local and central laboratory functions in a worldwide multicentre study: Experience from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study

Abstract

Background Measurement of glucose in multiple Field Laboratories requires rigorous standardization when patients and caregivers are masked, unless predefined thresholds are met. Local misclassification of participants at the thresholds can introduce recruitment bias and adversely affect the integrity of study findings.

Purpose To describe the challenges and the approach to meeting them in measuring glucose, HbA1c, and C-peptide in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. HAPO is an observational epidemiologic study of 25 000 pregnant women from 15 centres in 10 countries, designed to clarify unanswered questions on associations of maternal glycemia, less severe than overt diabetes mellitus, with risks of adverse pregnancy outcome.

Methods Glucose tolerance (75 g two-hour OGTT) is assessed locally at 24-32 weeks’ gestation, with results masked if fasting and two-hour plasma glucose are ≤5.8 mmol/L and ≤11.1 mmol/L, respectively. For analysis of outcomes HAPO utilizes measurements of glucose, C-peptide, and HbA1c on frozen samples in a Central Laboratory; measurement of HbA1c on stored, frozen blood also creates special challenges. A common external quality assessment scheme was used to standardize glucose measurements between Field Centre and Central Laboratories before and during data collection.

Results Agreement between Field Centres and the Central Laboratory in rates above the masking thresholds has been excellent (Kappa = 0.79, P < 0.001), with rates of 1.8 and 1.7% respectively. Percent technical error for Central Laboratory OGTT measurements of glucose, C-peptide, and HbA1c, were 2.0, 4.2, and 2.0, respectively.

Limitations It is not possible to assess if comparable results could have been obtained with a less rigorous approach to standardization.

Conclusions HAPO has been successful in ensuring comparability of glucose measurement between its Central Laboratory and Field Centre laboratories and in measuring its key metabolites with accuracy and precision. Recruitment bias based on glucose measurement has been avoided.

Get full access to this article

View all access options for this article.

References

Meinert CL , Tonascia S. Clinical trials: Design, conduct, and analysis. Oxford University Press , 1986.

HAPO Study Cooperative Research Group . The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study . Intl J Gynaecol Obstet 2002; 78: 69-77 .

Greene MF , Hare JW , Cloherty JP , Benacerraf BR , Soeldner JS. First trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy . Teratology 1989; 39: 225-231 .

Mills JL , Simpson JL , Driscoll SG et al. The NICHHD-diabetes in early pregnancy study: incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception . N Engl J Med 1988; 319: 1617-1623 .

WHO/EMC/97.3. Guidelines for the safe transport of infectious substances and diagnostic specimens. Available from http://www.who.int/emc.

O’Rahilly S , Burnett MA , Smith RF , Darley JH , Turner RC. Haemolysis affects insulin but not C-peptide immunoassay . Diabetologia 1987; 30: 394-396 .

The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes . N Engl J Med 1993; 329: 977-986 .

The Diabetes Prevention Program Research Group . Strategies to identify adults at high risk for type 2 diabetes . Diabetes Care 2005; 28: 150-156 .

Dyer AR , Greenland P , Elliott P et al. , for the INTERMAP Research Group . Estimating laboratory precision of urinary albumin excretion and other urinary measures in the INTERMAP study of macronutrients and blood pressure . Am J Epidemiol 2004; 160: 287-294 .

10.

Rosner B. Fundamentals of biostatistics, 5th edition. Duxbury , 2000: 410-410.

11.

Haeckel R , Wosniok W , Puentmann I. Discordance rate, a new concept for combining diagnostic decisions with analytical performance characteristics. 1. Application in method or sample system comparisons and in defining decision limits . Clin Chem Lab Med 2003; 41: 347-355 .

12.

Home PD , Alberti KG , Rodger NW , Burrin JM. Conference on insulin pump therapy in diabetes. Multicentre study of effect on microvascular disease. The Central Biochemistry Laboratory in the Multicentre Kroc Study. Problems and proposals . Diabetes 1985; 34(Suppl 3): 17-21 .

13.

The Diabetes Prevention Program Research Group . The Diabetes Prevention Program. Baseline characteristics of the randomized cohort . Diabetes Care 2000; 23: 1619-1629 .

14.

Chuang L-M , Tsai ST , Huang BY , Tai TY on behalf of the Diabcare-Asia 1998 Study Group . The status of diabetes control in Asia-a cross-sectional survey of 24 317 patients with diabetes mellitus in 1998 . Diabetic Medicine 2002; 19: 978-985 .